{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:19:25Z","timestamp":1775744365602,"version":"3.50.1"},"reference-count":168,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.contraception.2010.11.004","type":"journal-article","created":{"date-parts":[[2010,12,25]],"date-time":"2010-12-25T04:18:04Z","timestamp":1293250684000},"page":"19-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["The evolution of combined oral contraception: improving the risk-to-benefit ratio"],"prefix":"10.1016","volume":"84","author":[{"given":"Ronald","family":"Burkman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Serfaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2010.11.004_bb0005","unstructured":"United Nations Department of Economic and Social Affairs. World contraceptive use 2007. 2007."},{"key":"10.1016\/j.contraception.2010.11.004_bb0010","series-title":"Population reports, Series A, No. 9","article-title":"Oral contraceptives\u2014an update","author":"Blackburn","year":"2000"},{"key":"10.1016\/j.contraception.2010.11.004_bb0015","series-title":"Save the children. State of the world's mothers 2007: saving the lives of children under 5","year":"2007"},{"key":"10.1016\/j.contraception.2010.11.004_bb0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/bmj.2.5703.203","article-title":"Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs","volume":"2","author":"Inman","year":"1970","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2010.11.004_bb0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2008.02.020","article-title":"Oral contraceptives and individual variability of circulating levels of ethinyl estradiol and progestins","volume":"78","author":"Goldzieher","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1783\/147118908786000451","article-title":"Ovulation incidence with oral contraceptives: a literature review","volume":"34","author":"Milsom","year":"2008","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.11.004_bb0035","first-page":"CD003989","article-title":"20 microg versus >20 microg estrogen combined oral contraceptives for contraception","author":"Gallo","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2010.11.004_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2007.09.001","article-title":"Reducing unintended pregnancy in the United States","volume":"77","author":"Trussell","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0010-7824(99)00109-2","article-title":"Efficacy, cycle control and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations","volume":"60","author":"Rosenberg","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0050","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(61)91061-3","article-title":"Pulmonary embolism","author":"Jordan","year":"1961","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.11.004_bb0055","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.11.004_bb0060","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/bmj.292.6519.526","article-title":"Oral contraceptives and venous thromboembolism: findings in a large prospective study","volume":"292","author":"Vessey","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.contraception.2010.11.004_bb0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115799","article-title":"Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease","volume":"133","author":"Gerstman","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case\u2013control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0075","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case\u2013control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2010.11.004_bb0080","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0029-7844(96)00351-1","article-title":"Myocardial infarction in users of low-dose oral contraceptives","volume":"88","author":"Sidney","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0085","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/oxfordjournals.aje.a115592","article-title":"Oral contraceptive use and the risk of myocardial infarction","volume":"131","author":"Rosenberg","year":"1990","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0090","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1471-0528.1991.tb15397.x","article-title":"Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of a case\u2013control study","volume":"98","author":"Thorogood","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0095","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.fertnstert.2006.11.206","article-title":"A prospective study of oral contraceptive use and risk of myocardial infarction among Swedish women","volume":"88","author":"Margolis","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.11.004_bb0100","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2010.11.004_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500148875","article-title":"Pharmacology of estrogens and progestogens: influence of different routes of administration","volume":"8","author":"Kuhl","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2010.11.004_bb0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.maturitas.2008.11.013","article-title":"Classification and pharmacology of progestins","volume":"61","author":"Schindler","year":"2008","journal-title":"Maturitas"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2010.11.004_bb0115","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","article-title":"Classification and pharmacology of progestins","volume":"46","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2010.11.004_bb0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2010.11.004_bb0125","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.11.004_bb0130","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.11.004_bb0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case\u2013control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"312","author":"Spitzer","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2010.11.004_bb0140","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1136\/bmj.311.7020.1637","article-title":"Scare over oral contraceptives. Effect on behaviour of women attending a family planning clinic","volume":"311","author":"Armstrong","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2010.11.004_bb0145","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1136\/bmj.313.7063.1005b","article-title":"Terminations of pregnancy, not unplanned deliveries, increased as result of pill scare","volume":"313","author":"Child","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2010.11.004_bb0150","first-page":"996","article-title":"Pill scare linked to rise in abortions","volume":"312","author":"Dillner","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2010.11.004_bb0155","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3109\/00016349609054703","article-title":"The recent pill scare and number of legal abortions in Norway","volume":"75","author":"Iversen","year":"1996","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2010.11.004_bb0160","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/humupd\/5.6.746","article-title":"The changing scene\u2014an unnecessary pill crisis","volume":"5","author":"Heinemann","year":"1999","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2010.11.004_bb0165","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/13625180008500392","article-title":"Venous thromboembolism and oral contraceptive use: a methodological study of diagnostic suspicion and referral bias","volume":"5","author":"Heinemann","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.11.004_bb0170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0010-7824(97)00119-4","article-title":"First-time use of newer oral contraceptives and the risk of venous thromboembolism","volume":"56","author":"Suissa","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0175","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2125.2000.00198.x","article-title":"A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives","volume":"49","author":"Farmer","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0180","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0010-7824(01)00309-2","article-title":"Case\u2013control studies on venous thromboembolism: bias due to design? A methodological study on venous thromboembolism and steroid hormone use","volume":"65","author":"Heinemann","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0185","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2010.11.004_bb0190","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/humupd\/5.6.707","article-title":"The Transnational Study on Oral Contraceptives and the Health of Young Women. Methods, results, new analyses and the healthy user effect","volume":"5","author":"Lewis","year":"1999","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.contraception.2010.11.004_bb0195","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/humrep\/14.6.1493","article-title":"The differential risk of oral contraceptives: the impact of full exposure history","volume":"14","author":"Lewis","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.11.004_bb0200","first-page":"711","article-title":"Increased risk from third-generation progestogens: fuzzy logic or fuzzy science?","volume":"41","author":"Corson","year":"1996","journal-title":"J Reprod Med"},{"key":"10.1016\/j.contraception.2010.11.004_bb0205","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0010-7824(98)00019-5","article-title":"Hormonal contraception and risk of cardiovascular disease. An international perspective","volume":"57","author":"Farley","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0210","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(05)60173-0","article-title":"Third-generation oral contraceptives and venous thrombosis","volume":"349","author":"Jick","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.11.004_bb0215","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0010-7824(96)00035-2","article-title":"Oral contraceptives and thrombotic diseases: impact of new epidemiological studies","volume":"53","author":"Lidegaard","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0220","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0002-9378(97)70289-8","article-title":"Third-generation oral contraceptive and deep venous thrombosis: from epidemiologic controversy to new insight in coagulation","volume":"177","author":"Vandenbroucke","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0225","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/humrep\/15.4.817","article-title":"Recurrent use of newer oral contraceptives and the risk of venous thromboembolism","volume":"15","author":"Suissa","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.11.004_bb0230","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/humrep\/14.6.1500","article-title":"Venous thromboembolic disease and combined oral contraceptives: a re-analysis of the MediPlus database","volume":"14","author":"Todd","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.11.004_bb0235","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(96)07496-X","article-title":"Population-based study of risk of venous thromboembolism associated with various oral contraceptives","volume":"349","author":"Farmer","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.11.004_bb0240","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0010-7824(98)00002-X","article-title":"The risks of venous thromboembolic disease among German women using oral contraceptives: a database study","volume":"57","author":"Farmer","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0245","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.contraception.2006.02.002","article-title":"Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0250","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0255","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1056\/NEJM198108203050802","article-title":"Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives","volume":"305","author":"Slone","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.11.004_bb0260","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/bmj.2.5965.245","article-title":"Oral contraceptives and death from myocardial infarction","volume":"2","author":"Mann","year":"1975","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2010.11.004_bb0265","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/bmj.3.5984.631","article-title":"Oral contraceptives and myocardial infarction in young women: a further report","volume":"3","author":"Mann","year":"1975","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2010.11.004_bb0270","first-page":"94","article-title":"Risk factors for myocardial infarction in young women","volume":"30","author":"Mann","year":"1976","journal-title":"Br J Prev Soc Med"},{"key":"10.1016\/j.contraception.2010.11.004_bb0275","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/bmj.2.6033.445","article-title":"Oral contraceptive use in older women and fatal myocardial infarction","volume":"2","author":"Mann","year":"1976","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2010.11.004_bb0280","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bmj.2.5965.241","article-title":"Myocardial infarction in young women with special reference to oral contraceptive practice","volume":"2","author":"Mann","year":"1975","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2010.11.004_bb0285","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1056\/NEJM198808043190503","article-title":"A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women","volume":"319","author":"Stampfer","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.11.004_bb0290","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/bmj.298.6667.165","article-title":"Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study","volume":"298","author":"Croft","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2010.11.004_bb0295","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.1987.03400100073023","article-title":"The relative impact of smoking and oral contraceptive use on women in the United States","volume":"258","author":"Goldbaum","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2010.11.004_bb0300","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0010-7824(98)00016-X","article-title":"Oral contraceptive use and myocardial infarction","volume":"57","author":"Petitti","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0305","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1001\/jama.1985.03350440043028","article-title":"Myocardial infarction and cigarette smoking in women younger than 50 years of age","volume":"253","author":"Rosenberg","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2010.11.004_bb0310","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(79)91205-4","article-title":"Oral-contraceptive use in relation to myocardial infarction","volume":"1","author":"Shapiro","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.11.004_bb0315","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0140-6736(97)02358-1","article-title":"Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case\u2013control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.11.004_bb0320","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/bmj.318.7198.1579","article-title":"Oral contraceptives and myocardial infarction: results of the MICA case\u2013control study","volume":"318","author":"Dunn","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2010.11.004_bb0325","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa003216","article-title":"Oral contraceptives and the risk of myocardial infarction","volume":"345","author":"Tanis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.11.004_bb0330","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1093\/humrep\/17.9.2307","article-title":"Myocardial infarction and third generation oral contraceptives: aggregation of recent studies","volume":"17","author":"Spitzer","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.11.004_bb0335","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jacc.2008.09.042","article-title":"Contraceptive hormone use and cardiovascular disease","volume":"53","author":"Shufelt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0340","first-page":"1","article-title":"Clinical use of biphasic and triphasic pills","volume":"19","author":"Cohen","year":"1985","journal-title":"IPPF Med Bull"},{"key":"10.1016\/j.contraception.2010.11.004_bb0345","first-page":"CD003283","article-title":"Biphasic versus triphasic oral contraceptives for contraception","volume":"3","author":"Van Vliet","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2010.11.004_bb0350","first-page":"CD002032","article-title":"Biphasic versus monophasic oral contraceptives for contraception","volume":"3","author":"Van Vliet","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2010.11.004_bb0355","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/AOG.0b013e3181beab47","article-title":"Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trial","volume":"114","author":"Kaunitz","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0360","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.contraception.2004.12.005","article-title":"Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism","volume":"71","author":"Klipping","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0365","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.contraception.2009.03.013","article-title":"Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24\/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21\/7 combined oral contraceptive","volume":"80","author":"Anttila","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0370","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2006.08.004","article-title":"Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg\/ethinyl estradiol 20 micro g (Loestrin 24 Fe)","volume":"75","author":"Nakajima","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0375","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(03)00141-0","article-title":"A multicenter, randomized study of an extended cycle oral contraceptive","volume":"68","author":"Anderson","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0380","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.contraception.2005.09.010","article-title":"Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol","volume":"73","author":"Anderson","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0385","series-title":"YAZ [package insert]","year":"2007"},{"key":"10.1016\/j.contraception.2010.11.004_bb0390","first-page":"CD004695","article-title":"Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception","author":"Edelman","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2010.11.004_bb0395","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1210\/jc.2007-2287","article-title":"Effects of continuous versus cyclical oral contraception: a randomized controlled trial","volume":"93","author":"Legro","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.11.004_bb0400","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.contraception.2007.01.014","article-title":"Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen","volume":"75","author":"Coffee","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0405","first-page":"653","article-title":"Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial","volume":"101","author":"Miller","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0410","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.contraception.2006.07.005","article-title":"Evaluation of a continuous regimen of levonorgestrel\/ethinyl estradiol: phase 3 study results","volume":"74","author":"Archer","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0415","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0378-5122(94)00856-3","article-title":"Oral contraceptive containing natural estradiol for premenopausal women","volume":"21","author":"Hirvonen","year":"1995","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2010.11.004_bb0420","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0940-2993(98)80034-1","article-title":"Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives","volume":"50","author":"Hoffmann","year":"1998","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0425","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0015-0282(16)56210-4","article-title":"Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17 beta-estradiol","volume":"60","author":"Wenzl","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2010.11.004_bb0430","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0010-7824(80)90010-4","article-title":"Task Force on Oral Contraceptives. A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception","volume":"21","author":"Koetsawang","year":"1980","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0435","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2165\/11202820-000000000-00000","article-title":"Estradiol valerate\/dienogest: in oral contraception","volume":"69","author":"Hoy","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.contraception.2010.11.004_bb0440","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.contraception.2008.05.004","article-title":"Ovulation inhibition with four variations of a four-phasic estradiol valerate\/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies","volume":"78","author":"Endrikat","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0445","first-page":"70","article-title":"Antiandrogenic properties of nomegestrol acetate","volume":"45","author":"Duc","year":"1995","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.contraception.2010.11.004_bb0450","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.maturitas.2008.11.011","article-title":"Pharmacological profile of progestins","volume":"61","author":"Sitruk-Ware","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2010.11.004_bb0455","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1210\/jcem.84.11.6162","article-title":"The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women","volume":"84","author":"Couzinet","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.11.004_bb0460","first-page":"699","article-title":"Interaction of new 19 nor progesterone derivatives with progestagen, mineralocorticoid and glucocorticoid cytosolic receptors","volume":"17","author":"Botella","year":"1986","journal-title":"J Pharmacol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0465","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0960-0760(95)00171-U","article-title":"Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity","volume":"55","author":"Catherino","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0470","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0960-0760(93)90105-6","article-title":"Enzyme immunoassay for nomegestrol acetate in human plasma","volume":"46","author":"Ezan","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0475","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1471-0528.1987.tb02322.x","article-title":"Effect of nomegestrol acetate, a new 19-nor-progesterone derivative, on pituitary\u2013ovarian function in women","volume":"94","author":"Bazin","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0480","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1297-9589(02)00009-7","article-title":"Antigonadotropic effects of a 19-nor-progesterone derivative: the example of nomegestrol acetate","volume":"31","author":"Jamin","year":"2003","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.contraception.2010.11.004_bb0485","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0010-7824(91)90080-Y","article-title":"Effects of nomegestrol acetate (5 mg\/d) on hormonal, metabolic and hemostatic parameters in premenopausal women","volume":"44","author":"Basdevant","year":"1991","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0490","first-page":"441","article-title":"Effects of nomegestrol acetate on carbohydrate metabolism","volume":"19","author":"Dorangeon","year":"1993","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.contraception.2010.11.004_bb0495","article-title":"Synergistic effect of 17 \u03b2-estradiol and nomegestrol acetate used in a new monophasic oral contraceptive","author":"Chabbert-Buffet","year":"2009"},{"key":"10.1016\/j.contraception.2010.11.004_bb0500","article-title":"Comparison of two regimens of new monophasic oral contraceptive combining 17 beta-estradiol and nomegestrol acetate","author":"Serfaty","year":"2009"},{"key":"10.1016\/j.contraception.2010.11.004_bb0505","series-title":"World Health Organization, Guttmacher Institute","article-title":"Facts on induced abortion worldwide","author":"World Health Organization GI","year":"2007"},{"key":"10.1016\/j.contraception.2010.11.004_bb0510","first-page":"23","article-title":"Fertility, family planning and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. National Center for Health Statistics","author":"Chandra","year":"2005","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.contraception.2010.11.004_bb0515","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1363\/3904807","article-title":"U.S. women's one-year contraceptive use patterns, 2004","volume":"39","author":"Frost","year":"2007","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2010.11.004_bb0520","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2307\/2137932","article-title":"The causes of unmet need for contraception and the social content of services","volume":"26","author":"Bongaarts","year":"1995","journal-title":"Stud Fam Plann"},{"key":"10.1016\/j.contraception.2010.11.004_bb0525","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1056\/NEJM198703123161102","article-title":"The reduction in risk of ovarian cancer associated with oral-contraceptive use. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.11.004_bb0530","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bjc.1983.127","article-title":"The epidemiology of endometrial cancer in young women","volume":"47","author":"Henderson","year":"1983","journal-title":"Br J Cancer"},{"key":"10.1016\/j.contraception.2010.11.004_bb0535","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/jama.1982.03320290021022","article-title":"Protection against endometrial carcinoma by combination-product oral contraceptives","volume":"247","author":"Hulka","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2010.11.004_bb0540","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM198010303031807","article-title":"Decreased risk of endometrial cancer among oral-contraceptive users","volume":"303","author":"Kaufman","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.11.004_bb0545","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJM198003063021004","article-title":"Incidence of endometrial cancer in relation to the use of oral contraceptives","volume":"302","author":"Weiss","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.11.004_bb0550","series-title":"An interim report\u2014a comparison of disease occurrence leading hospitalization or death in users and nonusers of oral contraceptives","first-page":"349","article-title":"The Walnut Creek Contraceptive Drug Study: a prospective study of the side effects of oral contraceptives. Vol. 3","author":"Ramcharan","year":"1985"},{"key":"10.1016\/j.contraception.2010.11.004_bb0555","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/oxfordjournals.aje.a113417","article-title":"A case\u2013control study of cancer of the endometrium","volume":"116","author":"Kelsey","year":"1982","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0560","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/bmj.318.7176.96","article-title":"Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study","volume":"318","author":"Beral","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2010.11.004_bb0565","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00001648-199805000-00014","article-title":"Oral contraceptive use and risk of colorectal cancer","volume":"9","author":"Fernandez","year":"1998","journal-title":"Epidemiology"},{"key":"10.1016\/j.contraception.2010.11.004_bb0570","first-page":"4936","article-title":"A case\u2013control study of large bowel cancer and hormone exposure in women","volume":"49","author":"Furner","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.contraception.2010.11.004_bb0575","first-page":"1","article-title":"A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer","volume":"6","author":"Martinez","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.contraception.2010.11.004_bb0580","first-page":"703","article-title":"Large bowel cancer in women in relation to reproductive and hormonal factors: a case\u2013control study","volume":"71","author":"Potter","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.contraception.2010.11.004_bb0585","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0010-7824(90)90123-D","article-title":"Oral contraceptive use does not protect against large bowel cancer","volume":"41","author":"Kune","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0590","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00001648-199701000-00012","article-title":"Reproductive factors, oral contraceptive use, and risk of colorectal cancer","volume":"8","author":"Troisi","year":"1997","journal-title":"Epidemiology"},{"key":"10.1016\/j.contraception.2010.11.004_bb0595","first-page":"57","article-title":"Incidence of cancer of the large bowel in women in relation to reproductive and hormonal factors","volume":"67","author":"Weiss","year":"1981","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.contraception.2010.11.004_bb0600","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53\u00a0297 women with breast cancer and 100\u00a0239 women without breast cancer from 54 epidemiological studies","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.11.004_bb0605","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.bjc.6603260","article-title":"Oral contraceptive use and cancer. Findings in a large cohort study, 1968\u20132004","volume":"95","author":"Vessey","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.contraception.2010.11.004_bb0610","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2010.11.004_bb0615","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","article-title":"Oral contraceptives and the risk of breast cancer","volume":"346","author":"Marchbanks","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.11.004_bb0620","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4065\/81.10.1290","article-title":"Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis","volume":"81","author":"Kahlenborn","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.contraception.2010.11.004_bb0625","unstructured":"Cibula D, Gompel A, Mueck AO, La Vecchia C, Hannaford PC, Skouby SO, Zikan M, Dusek L. Hormonal contraception and risk of cancer. Hum Reprod Update."},{"issue":"Suppl 10","key":"10.1016\/j.contraception.2010.11.004_bb0630","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1016\/j.vaccine.2008.05.064","article-title":"Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia","volume":"26","author":"Bosch","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.contraception.2010.11.004_bb0635","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(02)08150-3","article-title":"Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case\u2013control study","volume":"359","author":"Moreno","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.11.004_bb0640","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3109\/00016349209021075","article-title":"Oral contraceptives and cancer of the cervix uteri. A meta-analysis","volume":"71","author":"Delgado-Rodriguez","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2010.11.004_bb0645","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies","volume":"370","author":"Appleby","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.11.004_bb0650","unstructured":"Farr S, Folger SG, Paulen M, Tepper N, Whiteman M, Zapata L, Culwell K, Kapp N, Cansino C. U S. medical eligibility criteria for contraceptive use, 2010: adapted from the World Health Organization medical eligibility criteria for contraceptive use, 4th ed. MMWR Recomm Rep 59:1\u201386."},{"key":"10.1016\/j.contraception.2010.11.004_bb0655","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0037-1613379","article-title":"Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use","volume":"89","author":"Abdollahi","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2010.11.004_bb0660","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jama.1997.03540320044033","article-title":"A prospective study of risk factors for pulmonary embolism in women","volume":"277","author":"Goldhaber","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2010.11.004_bb0665","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1111\/j.1538-7836.2006.02119.x","article-title":"Body mass index and the risk of venous thrombosis among postmenopausal women","volume":"4","author":"Oren","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2010.11.004_bb0670","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1001\/archinte.160.22.3415","article-title":"An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study","volume":"160","author":"Samama","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.contraception.2010.11.004_bb0675","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.amjmed.2005.03.012","article-title":"Obesity as a risk factor in venous thromboembolism","volume":"118","author":"Stein","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.contraception.2010.11.004_bb0680","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/archinte.162.10.1182","article-title":"Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology","volume":"162","author":"Tsai","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.contraception.2010.11.004_bb0685","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2141.2002.03563.x","article-title":"Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors","volume":"118","author":"Vaya","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0690","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1056\/NEJM200012143432403","article-title":"Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty","volume":"343","author":"White","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.11.004_bb0695","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1160\/TH03-01-0014","article-title":"Association between obesity and a prothrombotic state: the Framingham Offspring Study","volume":"91","author":"Rosito","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2010.11.004_bb0700","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case\u2013control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.11.004_bb0705","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13625180008500402","article-title":"The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives","volume":"5","author":"Nightingale","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.11.004_bb0710","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2141.2007.06780.x","article-title":"Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations","volume":"139","author":"Pomp","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0715","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1160\/TH08-10-0684","article-title":"Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry","volume":"101","author":"Blanco-Molina","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2010.11.004_bb0720","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.contraception.2008.12.013","article-title":"Association between efficacy and body weight or body mass index for two low-dose oral contraceptives","volume":"79","author":"Burkman","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0725","doi-asserted-by":"crossref","unstructured":"Westhoff CL, Torgal AH, Mayeda ER, Stanczyk FZ, Lerner JP, Benn EK, Paik M. Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial. Obstet Gynecol. 2010;116:275\u201383.","DOI":"10.1097\/AOG.0b013e3181e79440"},{"key":"10.1016\/j.contraception.2010.11.004_bb0730","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/AOG.0b013e3181ae9c64","article-title":"Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review","volume":"114","author":"Culwell","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0735","series-title":"Selected practice recommendations for contraceptive use","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.contraception.2010.11.004_bb0740","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/BOR.0b013e32832a2e16","article-title":"Environmental influences on risk for rheumatoid arthritis","volume":"21","author":"Liao","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0745","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jns.2009.04.038","article-title":"Oral contraceptives and the risk of multiple sclerosis: a review of the epidemiologic evidence","volume":"286","author":"Alonso","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.contraception.2010.11.004_bb0750","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/thx.56.8.613","article-title":"Exogenous female sex steroid hormones and risk of asthma and asthma-like symptoms: a cross sectional study of the general population","volume":"56","author":"Lange","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.contraception.2010.11.004_bb0755","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2008.10.041","article-title":"Oral contraception, body mass index and asthma: a cross-sectional Nordic\u2013Baltic population survey","volume":"123","author":"Macsali","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0760","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jbspin.2008.09.014","article-title":"Impact of combined and progestogen-only contraceptives on bone mineral density","volume":"76","author":"Sarfati","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.contraception.2010.11.004_bb0765","first-page":"CD006033","article-title":"Steroidal contraceptives: effect on bone fractures in women","author":"Lopez","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2010.11.004_bb0770","series-title":"New frontiers in contraceptive research: a blueprint for action","author":"Institute of Medicine","year":"2004"},{"key":"10.1016\/j.contraception.2010.11.004_bb0775","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1210\/jc.2008-1846","article-title":"Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men","volume":"94","author":"Gu","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.11.004_bb0780","series-title":"Population council: research that makes a difference","article-title":"New and improved reproductive technologies","author":"Population Council","year":"2010"},{"key":"10.1016\/j.contraception.2010.11.004_bb0785","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1210\/jc.2008-2604","article-title":"Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men","volume":"94","author":"Mahabadi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2010.11.004_bb0790","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.contraception.2007.10.003","article-title":"study of the functional performance, safety and acceptability of the BufferGel Duet","volume":"77","author":"Ballagh","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0795","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-0897.2008.00670.x","article-title":"Safety analysis of the diaphragm in combination with lubricant or acidifying microbicide gels: effects on markers of inflammation and innate immunity in cervicovaginal fluid","volume":"61","author":"Anderson","year":"2009","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0800","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.contraception.2008.04.118","article-title":"SILCS diaphragm: postcoital testing of a new single-size contraceptive device","volume":"78","author":"Schwartz","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0805","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1034\/j.1600-0412.1999.780917.x","article-title":"The efficacy of intratubal silicone in the Ovabloc hysteroscopic method of sterilization","volume":"78","author":"Ligt-Veneman","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2010.11.004_bb0810","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1479-828X.2001.tb01311.x","article-title":"The safety and effectiveness of a new hysteroscopic method for permanent birth control: results of the first Essure pbc clinical study","volume":"41","author":"Kerin","year":"2001","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2010.11.004_bb0815","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0010-7824(97)00142-X","article-title":"Clinical trial of a vas deferens injectable contraceptive for the male","volume":"56","author":"Guha","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.11.004_bb0820","series-title":"Male contraception: present and future","article-title":"The soft hollow plug (\u201cSHUG\u201d): a potentially reversible vas deferens blocking device","author":"Zaneveld","year":"1998"},{"key":"10.1016\/j.contraception.2010.11.004_bb0825","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.vaccine.2006.07.055","article-title":"Injectable polymer microspheres enhance immunogenicity of a contraceptive peptide vaccine","volume":"25","author":"Cui","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.contraception.2010.11.004_bb0830","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1126\/science.1099743","article-title":"Reversible immunocontraception in male monkeys immunized with eppin","volume":"306","author":"O'Rand","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.contraception.2010.11.004_bb0835","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1172\/JCI33873","article-title":"As the world grows: contraception in the 21st century","volume":"118","author":"Aitken","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.contraception.2010.11.004_bb0840","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1189\/jlb.0708395","article-title":"Embryonic implantation: cytokines, adhesion molecules and immune cells in establishing an implantation environment","volume":"85","author":"van Mourik","year":"2009","journal-title":"J Leukoc Biol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410006426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410006426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:44:27Z","timestamp":1761432267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782410006426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":168,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0010782410006426"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2010.11.004","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evolution of combined oral contraception: improving the risk-to-benefit ratio","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2010.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}